Document is current
Any future updates will be listed below
-
Authors
Gajawelli, Niharika
Geoly, Andrew D.
Batail, Jean-Marie
Xiao, Xiaoqian
Maron-Katz, Adi
Cole, Eleanor
Azeez, Azeezat
Kratter, Ian H.
Saggar, Manish
Williams, Nolan R.
-
Funding
Funding for this research was provided by:
NIH Director’s New Innovator Award (MH119735)
Brain and Behavior Research Foundation
Charles R. Schwab
David and Amanda Chao Fund II
Amy Roth PhD Fund
The Neuromodulation Research Fund
The Lehman Family
Still Charitable Trust
Marshall and Dee Ann Payne Fund
Gordie Brookstone Fund
The Mellam Family Foundation
The Baszucki Brain Research Fund
- License Information
-
More Information
Article History
Received: 30 March 2023
Accepted: 15 May 2024
First Online: 6 July 2024
Competing interests
: N.R.W. is a named inventor on Stanford-owned intellectual property relating to accelerated TMS pulse pattern sequences and neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Magnus Medical, and Nooma as a paid advisor; and he has equity/stock options in Magnus Medical, NeuraWell, and Nooma. A.M.K. is a named inventor on Stanford-owned intellectual property relating to neuroimaging-based TMS targeting; she receives a salary from Magnus Medical and has equity/stock options in Magnus Medical. E.C. receives a salary from Magnus Medical and has equity/stock options in Magnus Medical. All other investigators declare no competing interests.
